Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumors

The Elecsys hCG + β-assay should have lower reference limits than recommended by the manufacturer, with important implications for tumor follow-up. Elevated hCG is rare with intact gonadal function, both in a normal population and among survivors of testicular cancer, and should lead to further investigations when encountered in clinical practice.